Wai Chun Bio-Technology Valuation
Is 660 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 660 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 660 (HK$0.07) is trading below our estimate of fair value (HK$22.7)
Significantly Below Fair Value: 660 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 660?
Key metric: As 660 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 660's PS Ratio? | |
|---|---|
| PS Ratio | 0.02x |
| Sales | HK$558.90m |
| Market Cap | HK$12.69m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.2x |
| Enterprise Value/EBITDA | 6x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 660's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.3x | ||
2147 Zhengwei Group Holdings | 0.07x | n/a | HK$40.3m |
1340 Huisheng International Holdings | 0.7x | n/a | HK$45.2m |
1695 S&P International Holding | 0.4x | n/a | HK$62.6m |
359 China Haisheng Juice Holdings | 0.04x | n/a | HK$63.2m |
660 Wai Chun Bio-Technology | 0.02x | n/a | HK$12.7m |
Price-To-Sales vs Peers: 660 is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (0.4x).
Price to Sales Ratio vs Industry
How does 660's PS Ratio compare vs other companies in the HK Food Industry?
| 7 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 0.5x | 5.0% | |
660 Wai Chun Bio-Technology | 0.02x | n/a | US$1.63m |
3838 China Starch Holdings | 0.08x | n/a | US$134.11m |
3999 DaChan Food (Asia) | 0.1x | n/a | US$80.95m |
| 7 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 0.5x | 13.6% | |
660 Wai Chun Bio-Technology | 0.02x | n/a | US$1.63m |
Price-To-Sales vs Industry: 660 is good value based on its Price-To-Sales Ratio (0x) compared to the Hong Kong Food industry average (0.5x).
Price to Sales Ratio vs Fair Ratio
What is 660's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.02x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 660's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Tsingtao Brewery
HK$86.1b
Engages in the production, distribution, wholesale, and retail sale of beer products in Mainland China, Hong Kong, Macau, and internationally.
168
HK$47.70
7D
-3.4%
1Y
-13.3%
Tsingtao Brewery
HK$86.1b
Engages in the production, distribution, wholesale, and retail sale of beer products in Mainland China, Hong Kong, Macau, and internationally.
168
HK$47.70
7D
-3.4%
1Y
-13.3%
WEILONG Delicious Global Holdings
HK$11.3b
Weilong Delicious Global Holdings Ltd. produces and sells spicy snack food.
9985
HK$4.81
7D
-15.9%
1Y
n/a